Department of Thyroid and Breast Surgery, the 960th Hospital of People's Liberation Army, Jinan, China.
Health company, 92667 Army of PLA, Qingdao, China.
Front Endocrinol (Lausanne). 2024 Sep 30;15:1428669. doi: 10.3389/fendo.2024.1428669. eCollection 2024.
To investigate diagnostic approaches for preoperative localization of secondary hyperparathyroidism, as well as to give surgeons with precise parathyroid gland localization and imaging so that surgery can be performed safely.
The clinical data of 710 patients with secondary hyperparathyroidism who underwent surgery in our center from October 2009 to October 2023 were retrospectively analyzed. The changes in calcium, phosphorus, and parathyroid hormone levels were observed to ascertain the anatomical location and number of parathyroid glands.
Among the 710 patients, 55 underwent total parathyroidectomy, the others underwent total parathyroidectomy with autotransplantation. In total, 2,658 parathyroid glands were removed, with 43 glands being removed in 35 reoperation cases. The median parathyroid hormone level at 6 months postoperatively was 13.40 (interquartile range, 7.00-29.80) pg/mL. The detection rates of the parathyroid glands before first and repeat surgeries were higher using Tc-MIBI SPECT/CT fusion imaging than ultrasound (0.05). The sensitivity of combined preoperative Tc-MIBI SPECT/CT and ultrasound was 92.31%, higher than that of either Tc-MIBI SPECT/CT fusion imaging or ultrasound alone ( < 0.05). The incidence of ectopic parathyroid glands was 23.8%, and the incidence of ectopic left lower parathyroid glands was 13.2%. The left lower parathyroid gland was the most prone to ectopia.
Tc-MIBI SPECT/CT fusion imaging, paired with high-frequency ultrasound, can be utilized to diagnose SHPT preoperatively. The most common ectopia site is the left lower parathyroid gland, which is located primarily in the thymus and superior mediastinum. Understanding the functional anatomical distribution of the parathyroid glands is critical for developing effective surgical methods for secondary hyperparathyroidism.
探讨继发性甲状旁腺功能亢进术前定位的诊断方法,为外科医生提供精确的甲状旁腺定位和影像学资料,使手术安全进行。
回顾性分析 2009 年 10 月至 2023 年 10 月我院收治的 710 例继发性甲状旁腺功能亢进症患者的临床资料。观察血钙、磷、甲状旁腺激素水平的变化,确定甲状旁腺的解剖位置和数量。
710 例患者中,55 例行甲状旁腺全切除术,其余患者行甲状旁腺全切除加自体移植术。共切除甲状旁腺 2658 个,35 例再次手术切除甲状旁腺 43 个。术后 6 个月甲状旁腺激素中位数为 13.40(四分位间距 7.00-29.80)pg/ml。第一次和再次手术前,Tc-MIBI SPECT/CT 融合显像检测甲状旁腺的检出率均高于超声(0.05)。术前 Tc-MIBI SPECT/CT 联合超声的灵敏度为 92.31%,高于 Tc-MIBI SPECT/CT 融合显像或超声单独检查(<0.05)。异位甲状旁腺的发生率为 23.8%,异位左甲状旁腺下极的发生率为 13.2%。左甲状旁腺下极最易发生异位。
Tc-MIBI SPECT/CT 融合显像联合高频超声可用于术前诊断 SHPT。最常见的异位部位是左甲状旁腺下极,主要位于胸腺和上纵隔。了解甲状旁腺的功能解剖分布对制定继发性甲状旁腺功能亢进的有效手术方法至关重要。